Sofia, Bulgaria, August 20, 2024 – According to the requirements of art. 100t of the Law on Public Offering of Securities (LPOS), “Sopharma” AD (SFA: “Bulgarian Stock Exchange” AD, SPH: Warsaw Stock Exchange) notifies that for July 2024 the Company recorded a decrease in sales of 2% compared to the same month of the previous year, incl. 16% increase in domestic sales and 11% decrease in export sales.

For the period from the beginning of 2024, the Company recorded a decrease in sales of 7%, incl. 6% increase of domestic sales and 15% decrease in export sales.